CMAUP Plant Collective Molecular Activities

Plant Name: Sidastrum acuminatum

Taxonomic Information:

Plant ID: NPO22447
Plant Latin Name: Sidastrum acuminatum
Taxonomy Genus: Sidastrum
Taxonomy Family: Malvaceae

Plant External Links:

NCBI TaxonomyDB: n.a.
Plant-of-the-World-Online: n.a.

Geographical Distribution

See the Plant Occurrence Worldwide with Latitude and Longitude Available

Collective Molecular Activities of the Plant

List of Human Proteins Collectively Targeted by the Plant

Target Activity Range: ≤ 1μM
Click Gene ID to Access Activity Profile of Individual Target

Target Class	Target Proteins
Small molecule receptor (family A GPCR)	GPR35;
Peptide receptor (family A GPCR)	NPSR1;
Protein Phosphatase	CDC25B;
Enzyme_unclassified	RECQL; TDP1; BLM; GLO1; HPGD; AKR1B10; ALOX12; HSD17B1; AKR1B1; HSD17B10; NOX4; APEX1; POLB;
Hydrolase	ACHE;
Isomerase	TOP2A;
Protein Kinase	TEK; INSR; AXL; MET; FLT3; CDK1; EGFR; PIM1; NUAK1; SRC; KDR; IGF1R; AURKB; CSNK2A1;
Lyase	CA12; CA7; CA4;
Nuclear hormone receptor subfamily 1 group C	PPARA;
Nuclear hormone receptor subfamily 1 group F	RORC;
Nuclear hormone receptor subfamily 3 group A	ESR2; ESR1;
Nuclear hormone receptor subfamily 1 group H	NR1H4;
Lysine demethylase	KDM4E;
Serine protease	F10; F2;
Aspartic protease	BACE1;
Metallo protease	MMP12;
Transcription Factor	HIF1A;
Transferase	FUT7;
SLC superfamily of solute carriers	SLC22A6;
Unclassified	SMAD3; LMNA; FABP5; HSPA1A;
Methyl-lysine/arginine binding protein	L3MBTL1;

List of Human Cytochrome P450 Enzymes Affected by the Plant

Activity Range: ≤ 1μM
Click Gene ID to Access Activity Profile of Individual Enzyme

Cytochrome P450 Enzymes:	CYP1B1; CYP1A1;

Detailed Information of Target Proteins

Protein Class	Gene ID	Protein Name	Uniprot ID	Target ChEMBL ID
Aspartic protease	BACE1	Beta-secretase 1	P56817	CHEMBL4822
Cytochrome P450 family 1	CYP1B1	Cytochrome P450 1B1	Q16678	CHEMBL4878
Cytochrome P450 family 1	CYP1A1	Cytochrome P450 1A1	P04798	CHEMBL2231
Enzyme_unclassified	RECQL	ATP-dependent DNA helicase Q1	P46063	CHEMBL1293236
Enzyme_unclassified	TDP1	Tyrosyl-DNA phosphodiesterase 1	Q9NUW8	CHEMBL1075138
Enzyme_unclassified	BLM	Bloom syndrome protein	P54132	CHEMBL1293237
Enzyme_unclassified	GLO1	Glyoxalase I	Q04760	CHEMBL2424
Enzyme_unclassified	HPGD	15-hydroxyprostaglandin dehydrogenase [NAD+]	P15428	CHEMBL1293255
Enzyme_unclassified	AKR1B10	Aldo-keto reductase family 1 member B10	O60218	CHEMBL5983
Enzyme_unclassified	ALOX12	Arachidonate 12-lipoxygenase	P18054	CHEMBL3687
Enzyme_unclassified	HSD17B1	Estradiol 17-beta-dehydrogenase 1	P14061	CHEMBL3181
Enzyme_unclassified	AKR1B1	Aldose reductase	P15121	CHEMBL1900
Enzyme_unclassified	HSD17B10	Endoplasmic reticulum-associated amyloid beta-peptide-binding protein	Q99714	CHEMBL4159
Enzyme_unclassified	NOX4	NADPH oxidase 4	Q9NPH5	CHEMBL1250375
Enzyme_unclassified	APEX1	DNA-(apurinic or apyrimidinic site) lyase	P27695	CHEMBL5619
Enzyme_unclassified	POLB	DNA polymerase beta	P06746	CHEMBL2392
Hydrolase	ACHE	Acetylcholinesterase	P22303	CHEMBL220
Isomerase	TOP2A	DNA topoisomerase II alpha	P11388	CHEMBL1806
Lyase	CA12	Carbonic anhydrase XII	O43570	CHEMBL3242
Lyase	CA7	Carbonic anhydrase VII	P43166	CHEMBL2326
Lyase	CA4	Carbonic anhydrase IV	P22748	CHEMBL3729
Lysine demethylase	KDM4E	Lysine-specific demethylase 4D-like	B2RXH2	CHEMBL1293226
Metallo protease	MMP12	Matrix metalloproteinase 12	P39900	CHEMBL4393
Methyl-lysine/arginine binding protein	L3MBTL1	Lethal(3)malignant brain tumor-like protein 1	Q9Y468	CHEMBL1287622
Nuclear hormone receptor subfamily 1 group C	PPARA	Peroxisome proliferator-activated receptor alpha	Q07869	CHEMBL239
Nuclear hormone receptor subfamily 1 group F	RORC	Nuclear receptor ROR-gamma	P51449	CHEMBL1741186
Nuclear hormone receptor subfamily 1 group H	NR1H4	Bile acid receptor FXR	Q96RI1	CHEMBL2047
Nuclear hormone receptor subfamily 3 group A	ESR2	Estrogen receptor beta	Q92731	CHEMBL242
Nuclear hormone receptor subfamily 3 group A	ESR1	Estrogen receptor alpha	P03372	CHEMBL206
Peptide receptor (family A GPCR)	NPSR1	Neuropeptide S receptor	Q6W5P4	CHEMBL5162
Protein Kinase	TEK	Tyrosine-protein kinase TIE-2	Q02763	CHEMBL4128
Protein Kinase	INSR	Insulin receptor	P06213	CHEMBL1981
Protein Kinase	AXL	Tyrosine-protein kinase receptor UFO	P30530	CHEMBL4895
Protein Kinase	MET	Hepatocyte growth factor receptor	P08581	CHEMBL3717
Protein Kinase	FLT3	Tyrosine-protein kinase receptor FLT3	P36888	CHEMBL1974
Protein Kinase	CDK1	Cyclin-dependent kinase 1	P06493	CHEMBL308
Protein Kinase	EGFR	Epidermal growth factor receptor erbB1	P00533	CHEMBL203
Protein Kinase	PIM1	Serine/threonine-protein kinase PIM1	P11309	CHEMBL2147
Protein Kinase	NUAK1	NUAK family SNF1-like kinase 1	O60285	CHEMBL5784
Protein Kinase	SRC	Tyrosine-protein kinase SRC	P12931	CHEMBL267
Protein Kinase	KDR	Vascular endothelial growth factor receptor 2	P35968	CHEMBL279
Protein Kinase	IGF1R	Insulin-like growth factor I receptor	P08069	CHEMBL1957
Protein Kinase	AURKB	Serine/threonine-protein kinase Aurora-B	Q96GD4	CHEMBL2185
Protein Kinase	CSNK2A1	Casein kinase II alpha	P68400	CHEMBL3629
Protein Phosphatase	CDC25B	Dual specificity phosphatase Cdc25B	P30305	CHEMBL4804
Serine protease	F10	Coagulation factor X	P00742	CHEMBL244
Serine protease	F2	Thrombin	P00734	CHEMBL204
SLC superfamily of solute carriers	SLC22A6	Solute carrier family 22 member 6	Q4U2R8	CHEMBL1641347
Small molecule receptor (family A GPCR)	GPR35	G-protein coupled receptor 35	Q9HC97	CHEMBL1293267
Transcription Factor	HIF1A	Hypoxia-inducible factor 1 alpha	Q16665	CHEMBL4261
Transferase	FUT7	Alpha-(1,3)-fucosyltransferase 7	Q11130	CHEMBL3596077
Unclassified	SMAD3	Mothers against decapentaplegic homolog 3	P84022	CHEMBL1293258
Unclassified	LMNA	Prelamin-A/C	P02545	CHEMBL1293235
Unclassified	FABP5	Fatty acid binding protein epidermal	Q01469	CHEMBL3674
Unclassified	HSPA1A	Heat shock 70 kDa protein 1	P0DMV8	CHEMBL5460

Enrichment of Gene Ontology of Target Proteins (Activity≤1μM)

Detailed Information of Enriched Gene Ontolgy

GO Type	GO Category	Enriched GO Terms	p-Value	Adjusted p-Value	Enriched Genes
BP	GO:0009987; cellular process	GO:0051897; positive regulation of protein kinase B signaling	1.088E-08	4.084E-06	AXL, EGFR, F10, INSR, MET, NOX4, SRC, TEK
MF	GO:0005488; binding	GO:0005524; ATP binding	6.747E-08	1.814E-05	AURKB, AXL, BLM, CDK1, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, RECQL, SRC, TEK, TOP2A
CC	GO:0043226; organelle	GO:0005654; nucleoplasm	1.599E-07	3.627E-05	AKR1B1, APEX1, AURKB, BLM, CDC25B, CDK1, CSNK2A1, ESR1, ESR2, FABP5, HIF1A, HPGD, HSPA1A, L3MBTL1, LMNA, NR1H4, NUAK1, PIM1, POLB, PPARA, RECQL, RORC, SMAD3, SRC, TOP2A
BP	GO:0008152; metabolic process	GO:0038083; peptidyl-tyrosine autophosphorylation	2.176E-07	4.738E-05	EGFR, IGF1R, INSR, KDR, SRC
MF	GO:0005488; binding	GO:0008270; zinc ion binding	3.331E-07	6.843E-05	BLM, CA12, CA4, CA7, ESR1, ESR2, GLO1, L3MBTL1, MMP12, NR1H4, PPARA, RORC, SMAD3
BP	GO:0009987; cellular process	GO:0030522; intracellular receptor signaling pathway	6.250E-07	1.106E-04	ESR1, ESR2, NR1H4, PIM1, PPARA, RORC, SRC
BP	GO:0050896; response to stimulus	GO:0001666; response to hypoxia	6.624E-07	1.127E-04	CYP1A1, HIF1A, LMNA, NOX4, PPARA, SMAD3, SRC, TEK
BP	GO:0009987; cellular process	GO:0070301; cellular response to hydrogen peroxide	8.188E-07	1.351E-04	AKR1B1, APEX1, AXL, CDK1, CYP1B1
MF	Unclassified;	GO:0004872; receptor activity	8.170E-07	1.351E-04	AXL, EGFR, ESR1, ESR2, F2, FLT3, GPR35, HPGD, IGF1R, INSR, KDR, MET, NPSR1, NR1H4, PPARA, RORC, TEK
BP	GO:0048511; rhythmic process	GO:0048511; rhythmic process	1.324E-06	2.017E-04	AXL, CSNK2A1, EGFR, ESR1, PPARA, RORC, SRC, TOP2A
MF	Unclassified;	GO:0004716; signal transducer, downstream of receptor, with protein tyrosine kinase activity	1.813E-06	2.685E-04	EGFR, INSR, KDR
BP	GO:0009987; cellular process	GO:0043401; steroid hormone mediated signaling pathway	1.831E-06	2.694E-04	ESR1, ESR2, NR1H4, PPARA, RORC, SRC
BP	GO:0032502; developmental process	GO:0031100; animal organ regeneration	2.462E-06	3.330E-04	AXL, CDK1, CSNK2A1, EGFR, FLT3
MF	GO:0005488; binding	GO:0042562; hormone binding	4.287E-06	5.396E-04	ACHE, EGFR, HSD17B1, IGF1R, INSR
MF	GO:0005488; binding	GO:0005496; steroid binding	4.542E-06	5.587E-04	ESR1, ESR2, HSD17B1, NR1H4, RORC
BP	GO:0008152; metabolic process	GO:0006367; transcription initiation from RNA polymerase II promoter	6.095E-06	7.253E-04	CDK1, ESR1, ESR2, NR1H4, PPARA, RORC
BP	GO:0008152; metabolic process	GO:0008202; steroid metabolic process	6.177E-06	7.310E-04	AKR1B1, AKR1B10, CYP1A1, CYP1B1, ESR1, HSD17B1, NR1H4
BP	GO:0009987; cellular process	GO:0001961; positive regulation of cytokine-mediated signaling pathway	6.684E-06	7.784E-04	AXL, HIF1A, HSPA1A, MMP12
BP	GO:0009987; cellular process	GO:0006286; base-excision repair, base-free sugar-phosphate removal	7.961E-06	8.935E-04	APEX1, POLB
MF	GO:0060089; molecular transducer activity	GO:0038052; RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding	7.961E-06	8.935E-04	ESR1, ESR2
MF	GO:0003824; catalytic activity	GO:0004089; carbonate dehydratase activity	9.701E-06	1.046E-03	CA12, CA4, CA7
MF	Unclassified;	GO:0032403; protein complex binding	1.221E-05	1.255E-03	ACHE, APEX1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, PPARA, SMAD3, SRC
BP	GO:0008152; metabolic process	GO:0045740; positive regulation of DNA replication	1.801E-05	1.720E-03	CDK1, EGFR, IGF1R, INSR
CC	GO:0016020; membrane	GO:0045121; membrane raft	1.872E-05	1.757E-03	BACE1, EGFR, INSR, KDR, SLC22A6, SRC, TEK
BP	GO:0050896; response to stimulus	GO:0050728; negative regulation of inflammatory response	1.880E-05	1.757E-03	F2, NR1H4, PPARA, SMAD3, TEK
MF	GO:0003824; catalytic activity	GO:0016616; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor	2.218E-05	1.988E-03	AKR1B1, AKR1B10, HPGD, HSD17B1, HSD17B10
BP	GO:0008152; metabolic process	GO:0045893; positive regulation of transcription, DNA-templated	3.018E-05	2.537E-03	BLM, EGFR, ESR1, ESR2, HIF1A, INSR, MET, MMP12, NR1H4, PPARA, RORC, SMAD3, SRC, TOP2A
BP	GO:0009987; cellular process	GO:0030520; intracellular estrogen receptor signaling pathway	3.237E-05	2.680E-03	ESR1, ESR2, SRC
MF	GO:0005488; binding	GO:0019838; growth factor binding	3.395E-05	2.747E-03	EGFR, IGF1R, INSR, KDR, TEK
MF	GO:0005488; binding	GO:0042802; identical protein binding	3.421E-05	2.749E-03	ACHE, BLM, CSNK2A1, EGFR, ESR1, ESR2, FLT3, HPGD, IGF1R, KDR, L3MBTL1, MET, SLC22A6, SMAD3, TOP2A
BP	GO:0009987; cellular process	GO:0014068; positive regulation of phosphatidylinositol 3-kinase signaling	3.719E-05	2.977E-03	F2, FLT3, KDR, TEK
BP	GO:0008152; metabolic process	GO:0055114; oxidation-reduction process	3.770E-05	3.007E-03	AKR1B1, AKR1B10, ALOX12, APEX1, CYP1A1, CYP1B1, HPGD, HSD17B1, HSD17B10, KDM4E, NOX4
MF	GO:0005488; binding	GO:0034056; estrogen response element binding	4.759E-05	3.611E-03	ESR1, ESR2
BP	GO:0032502; developmental process	GO:0007568; aging	4.871E-05	3.657E-03	APEX1, AURKB, CDK1, CYP1A1, NOX4, POLB
BP	GO:0009987; cellular process	GO:0050714; positive regulation of protein secretion	5.359E-05	3.955E-03	ACHE, EGFR, HIF1A, MMP12, NR1H4, SRC
BP	GO:0008152; metabolic process	GO:0032787; monocarboxylic acid metabolic process	5.903E-05	4.270E-03	ALOX12, CYP1A1, CYP1B1, GLO1, HIF1A, HPGD, NR1H4, PPARA
BP	GO:0009987; cellular process	GO:0071363; cellular response to growth factor stimulus	6.750E-05	4.696E-03	EGFR, INSR, KDR, NOX4, SMAD3, SRC
BP	GO:0009987; cellular process	GO:0046427; positive regulation of JAK-STAT cascade	6.823E-05	4.731E-03	AKR1B1, CYP1B1, F2, FLT3
MF	GO:0005488; binding	GO:0043548; phosphatidylinositol 3-kinase binding	7.574E-05	5.203E-03	AXL, IGF1R, INSR
BP	GO:0032502; developmental process	GO:0045766; positive regulation of angiogenesis	7.614E-05	5.214E-03	ALOX12, CYP1B1, HIF1A, KDR, TEK
MF	GO:0003824; catalytic activity	GO:0009378; four-way junction helicase activity	7.917E-05	5.321E-03	BLM, RECQL
BP	GO:0008152; metabolic process	GO:0043552; positive regulation of phosphatidylinositol 3-kinase activity	8.398E-05	5.571E-03	FLT3, SRC, TEK
MF	GO:0005488; binding	GO:0003690; double-stranded DNA binding	1.005E-04	6.383E-03	APEX1, EGFR, ESR1, ESR2, HIF1A, NR1H4, PPARA, RORC, SMAD3, TDP1
BP	GO:0065007; biological regulation	GO:0043406; positive regulation of MAP kinase activity	1.018E-04	6.447E-03	CDK1, EGFR, FLT3, INSR, NOX4, SRC
MF	GO:0005488; binding	GO:0051879; Hsp90 protein binding	1.022E-04	6.450E-03	CSNK2A1, HIF1A, KDR
BP	GO:0008152; metabolic process	GO:1902893; regulation of pri-miRNA transcription from RNA polymerase II promoter	1.122E-04	6.920E-03	HIF1A, PPARA, SMAD3
BP	GO:0008152; metabolic process	GO:0010907; positive regulation of glucose metabolic process	1.122E-04	6.920E-03	INSR, PPARA, SRC
BP	GO:0008152; metabolic process	GO:2001300; lipoxin metabolic process	1.185E-04	7.250E-03	ALOX12, HPGD
BP	GO:0008152; metabolic process	GO:1903580; positive regulation of ATP metabolic process	1.228E-04	7.427E-03	CDK1, HIF1A, INSR
BP	GO:0008283; cell proliferation	GO:0050679; positive regulation of epithelial cell proliferation	1.390E-04	8.180E-03	EGFR, HIF1A, KDR, MMP12, TEK
BP	GO:0009987; cellular process	GO:1901796; regulation of signal transduction by p53 class mediator	1.428E-04	8.356E-03	AURKB, BLM, CSNK2A1, L3MBTL1, NUAK1
BP	GO:0008152; metabolic process	GO:0006730; one-carbon metabolic process	1.459E-04	8.502E-03	CA12, CA4, CA7
BP	GO:0032502; developmental process	GO:0002009; morphogenesis of an epithelium	1.460E-04	8.502E-03	EGFR, ESR1, HIF1A, MET, SMAD3, SRC
BP	GO:0032501; multicellular organismal process	GO:0007435; salivary gland morphogenesis	1.656E-04	9.369E-03	EGFR, POLB
MF	GO:0060089; molecular transducer activity	GO:0005021; vascular endothelial growth factor-activated receptor activity	1.656E-04	9.369E-03	FLT3, KDR
MF	GO:0098772; molecular function regulator	GO:0030235; nitric-oxide synthase regulator activity	1.656E-04	9.369E-03	EGFR, ESR1
MF	GO:0003824; catalytic activity	GO:0043140; ATP-dependent 3'-5' DNA helicase activity	1.656E-04	9.369E-03	BLM, RECQL
BP	GO:0008152; metabolic process	GO:0016101; diterpenoid metabolic process	1.675E-04	9.423E-03	AKR1B10, CYP1A1, CYP1B1, EGFR
BP	GO:0051179; localization	GO:0060341; regulation of cellular localization	1.735E-04	9.737E-03	CDK1, CSNK2A1, EGFR, F2, HIF1A, LMNA, NPSR1, NR1H4, SMAD3, SRC
BP	GO:0051179; localization	GO:0042307; positive regulation of protein import into nucleus	1.742E-04	9.753E-03	CDK1, EGFR, F2, SMAD3

Enriched KEGG Pathways of Target Proteins (Activity≤1μM)

Top 10 KEGG Pathways (ordered by adjusted p-value)

Detailed Information of Enriched KEGG Pathways

Pathway Category Top Level	Pathway Category Second Level	Pathway ID	Pathway Name	p-Value	Adjusted p-Value	Enriched Genes
09140 Cellular Processes	09144 Cellular community - eukaryotes	hsa04520	Adherens junction	1.250E-09	1.625E-07	SMAD3, CSNK2A1, SRC, INSR, MET, EGFR, IGF1R
09150 Organismal Systems	09152 Endocrine system	hsa04913	Ovarian steroidogenesis	2.518E-07	1.636E-05	HSD17B1, INSR, CYP1A1, CYP1B1, IGF1R
09160 Human Diseases	09161 Cancers	hsa05205	Proteoglycans in cancer	1.344E-06	5.653E-05	SRC, KDR, HIF1A, ESR1, MET, EGFR, IGF1R
09130 Environmental Information Processing	09132 Signal transduction	hsa04015	Rap1 signaling pathway	1.739E-06	5.653E-05	SRC, INSR, KDR, TEK, MET, EGFR, IGF1R
09140 Cellular Processes	09141 Transport and catabolism	hsa04144	Endocytosis	6.726E-06	1.663E-04	SMAD3, SRC, KDR, MET, EGFR, HSPA1A, IGF1R
09150 Organismal Systems	09152 Endocrine system	hsa04915	Estrogen signaling pathway	7.674E-06	1.663E-04	SRC, ESR1, EGFR, ESR2, HSPA1A
09130 Environmental Information Processing	09132 Signal transduction	hsa04066	HIF-1 signaling pathway	9.315E-06	1.730E-04	INSR, TEK, HIF1A, EGFR, IGF1R
09130 Environmental Information Processing	09132 Signal transduction	hsa04014	Ras signaling pathway	3.646E-05	4.740E-04	INSR, KDR, TEK, MET, EGFR, IGF1R
09160 Human Diseases	09161 Cancers	hsa05230	Central carbon metabolism in cancer	3.449E-05	4.740E-04	FLT3, MET, HIF1A, EGFR
09130 Environmental Information Processing	09132 Signal transduction	hsa04151	PI3K-Akt signaling pathway	3.372E-04	3.653E-03	INSR, KDR, TEK, MET, EGFR, IGF1R
09140 Cellular Processes	09144 Cellular community - eukaryotes	hsa04510	Focal adhesion	2.309E-04	2.729E-03	SRC, KDR, MET, EGFR, IGF1R
09160 Human Diseases	09161 Cancers	hsa05200	Pathways in cancer	7.513E-04	6.104E-03	SMAD3, FLT3, HIF1A, MET, EGFR, IGF1R
09130 Environmental Information Processing	09132 Signal transduction	hsa04068	FoxO signaling pathway	4.902E-04	4.902E-03	SMAD3, INSR, EGFR, IGF1R
09150 Organismal Systems	09149 Aging	hsa04213	Longevity regulating pathway - multiple species	7.281E-04	6.104E-03	INSR, HSPA1A, IGF1R
09160 Human Diseases	09167 Infectious diseases	hsa05120	Epithelial cell signaling in Helicobacter pylori infection	8.690E-04	6.646E-03	SRC, MET, EGFR
09160 Human Diseases	09161 Cancers	hsa05206	MicroRNAs in cancer	1.324E-03	8.605E-03	PIM1, CYP1B1, MET, EGFR, CDC25B
09160 Human Diseases	09161 Cancers	hsa05218	Melanoma	9.853E-04	7.021E-03	MET, EGFR, IGF1R
09100 Metabolism	09103 Lipid metabolism	hsa00140	Steroid hormone biosynthesis	5.455E-04	5.066E-03	HSD17B1, CYP1A1, CYP1B1
09150 Organismal Systems	09152 Endocrine system	hsa04917	Prolactin signaling pathway	1.026E-03	7.021E-03	SRC, ESR1, ESR2
09100 Metabolism	09102 Energy metabolism	hsa00910	Nitrogen metabolism	1.302E-05	2.116E-04	CA12, CA4, CA7
09160 Human Diseases	09161 Cancers	hsa05202	Transcriptional misregulation in cancer	1.513E-03	9.367E-03	HPGD, FLT3, MET, IGF1R

Human Diseases Associated with the Target Proteins of the Plant

Detailed Information of Human Diseases

ICD10 Disease Category	Disease Name	ICD10 Code	Associated Disease Targets (Association Ref: TTD database)
G00-G99: Diseases of the nervous system G00-G99	Motor neurone disease	G12.2	IGF1R;
G00-G99: Diseases of the nervous system G00-G99	Multiple scierosis	G35	ESR1; F2;
C00-D49: Neoplasms	Multiple myeloma	C90	IGF1R; SRC;
E00-E89: Endocrine, nutritional and metabolic diseases	Hunter syndrome	E76.1	INSR;
A00-B99: Certain infectious and parasitic diseases	Human immunodeficiency virus infection	B20-B26	FLT3;
Z00-Z99: Factors influencing health status and contact with health services	Hormone replacement therapy	Z79.890	ESR1;
E00-E89: Endocrine, nutritional and metabolic diseases	Hyperglycaemia in type 2 diabetes	E11, R73.9	INSR;
E00-E89: Endocrine, nutritional and metabolic diseases	Hypercholesterolemia	E78	INSR;
I00-I99: Diseases of the circulatory system	Myocardial infarction	I21, I22	F2;
E00-E89: Endocrine, nutritional and metabolic diseases	Estrogen deficiency	E28.39	ESR1;
C00-D49: Neoplasms	Colorectal cancer	C18-C21	IGF1R; KDR; FLT3; EGFR;
N00-N99: Diseases of the genitourinary system	Infertility	N97.0	ESR1;
E00-E89: Endocrine, nutritional and metabolic diseases	Diabetic complication	E08-E13	AKR1B1;
K00-K95: Diseases of the digestive system	Gastrointestinal disease	K00-K93	EGFR;
C00-D49: Neoplasms	Malignant adrenal gland cancer	C74.0	IGF1R;
C00-D49: Neoplasms	Acute myeloid leukemia	C92.0	AURKB; FLT3;
C00-D49: Neoplasms	Acute lymphoblastic leukemia	C91.0	FLT3;
NA: NA	Early satiation associated with functional dyspepsia	NA	ACHE;
N00-N99: Diseases of the genitourinary system	Dysmenorrhea	N94.4-N94.6	ESR1;
N00-N99: Diseases of the genitourinary system	Dyspareunia	N94.1	ESR1;
S00-T88: Injury, poisoning and certain other consequences of external causes	Vulnerary	S00-T98	EGFR;
C00-D49: Neoplasms	Colon cancer	C50	FLT3; EGFR;
C00-D49: Neoplasms	Renal cancer	C64	KDR; F10;
NA: NA	Nonvalvular atrial fibrillation	NA	F2;
C00-D49: Neoplasms	Non-small cell lung cancer	C33-C34	MET; IGF1R; KDR; AXL; EGFR;
C00-D49: Neoplasms	Non-small-cell lung cancer	NA	KDR;
E00-E89: Endocrine, nutritional and metabolic diseases	Non-insulin dependent diabetes	E11.9	INSR;
I00-I99: Diseases of the circulatory system	Atherosclerosis	I70	MMP12;
L00-L99: Diseases of the skin and subcutaneous tissue	Diabetic foot ulcer	L88-L89	EGFR;
E00-E89: Endocrine, nutritional and metabolic diseases	Diabetic cataract	E10.36, E11.36	AKR1B1;
G00-G99: Diseases of the nervous system G00-G99	Neurodegenerative disease	G30-G32	ACHE;
E00-E89: Endocrine, nutritional and metabolic diseases	Type 1 diabetes	E10	INSR;
K00-K95: Diseases of the digestive system	Xerostomia	K11.7, R68.2	ACHE;
I00-I99: Diseases of the circulatory system	Neurological disease	I21, I22, R52, R52.1-R52.2, R60.9, G89	ESR1; NPSR1; F2;
I00-I99: Diseases of the circulatory system	Angina pectoris	I20	F10; F2;
A00-B99: Certain infectious and parasitic diseases	Pediculus humanus capitis	B85.0	ACHE;
K00-K95: Diseases of the digestive system	Crohn's disease	K50	INSR;
A00-B99: Certain infectious and parasitic diseases	Cryptosporidium infection	A07.2	EGFR;
C00-D49: Neoplasms	Cutaneous Melanoma	C43-C44	KDR;
I00-I99: Diseases of the circulatory system	Deep vein thrombosis	I80-I82, I80.2	F10;
D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	Hemophilia	D66-D68	F10;
C00-D49: Neoplasms	Hematological malignancies	C81-C86	AURKB; SRC;
C00-D49: Neoplasms	Glioma	C71	KDR; EGFR;
H00-H59: Diseases of the eye and adnexa	Eye disorders	H00-H59	ESR1;
C00-D49: Neoplasms	Ovarian cancer	C56	KDR; EGFR;
C00-D49: Neoplasms	Osteosarcoma	C40-C41	SRC;
C00-D49: Neoplasms	Myeloid leukemia	C92	FLT3;
C00-D49: Neoplasms	Myelofibrosis	C94.4, D47.4	FLT3;
G00-G99: Diseases of the nervous system G00-G99	Myasthenia gravis	G70.0	ACHE;
I00-I99: Diseases of the circulatory system	Deep venous clots	I80.2	F10;
E00-E89: Endocrine, nutritional and metabolic diseases	Diabetes	E23.2, N25.1	INSR; AKR1B1;
J00-J99: Diseases of the respiratory system	Asthma	J45	MMP12;
C00-D49: Neoplasms	Urethral cancer	NA	EGFR;
NA: NA	Upper abdominal bloating	NA	ACHE;
N00-N99: Diseases of the genitourinary system	Urinary dysfunction	N39.3-N39.4	ACHE;
C00-D49: Neoplasms	Inflammatory breast cancer	C50	EGFR;
C00-D49: Neoplasms	Inflammatory disease	C11, C44, K75.9, M00-M25	MMP12;
F01-F99: Mental, Behavioral and Neurodevelopmental disorders	Cognitive disorders	F01-F07, F04, F05, R41.3	ACHE;
C00-D49: Neoplasms	CLL	NA	FLT3;
G00-G99: Diseases of the nervous system G00-G99	Pain	G64, G90.0, R52, G89	ESR1; CDK1; IGF1R; ACHE; INSR;
C00-D49: Neoplasms	Pancreatic cancer	C25	KDR; FLT3; EGFR;
C00-D49: Neoplasms	Medullary thyroid cancer	C73	KDR;
C00-D49: Neoplasms	Malignant tumor	C00-C75, C7A, C7B	EGFR;
C00-D49: Neoplasms	Renal cell carcinoma	NA	KDR;
E00-E89: Endocrine, nutritional and metabolic diseases	Type 2 diabetes	E11	INSR;
E00-E89: Endocrine, nutritional and metabolic diseases	Type 1/2 diabetes	E08-E13	INSR;
A00-B99: Certain infectious and parasitic diseases	Trematode infection	B66.9	ESR1;
N00-N99: Diseases of the genitourinary system	Irregularities	N92.6	ESR1;
I00-I99: Diseases of the circulatory system	Ischemia	I99.8	TEK; SRC;
C00-D49: Neoplasms	Chronic myelogenous leukaemia	C92.1	SRC;
C00-D49: Neoplasms	Chronic lymphocytic leukaemia	C91	EGFR;
M00-M99: Diseases of the musculoskeletal system and connective tissue	Osteoporosis	M80-M81, Z79.890	ESR1; SRC;
M00-M99: Diseases of the musculoskeletal system and connective tissue	Arthralgia	M25.5	ESR1;
M00-M99: Diseases of the musculoskeletal system and connective tissue	Arthritis	M00-M25	TEK;
I00-I99: Diseases of the circulatory system	Prophylaxis of deep vein thrombosis	I80-I82, I80.2	F10;
L00-L99: Diseases of the skin and subcutaneous tissue	Psoriasis	L40	FLT3; EGFR;
C00-D49: Neoplasms	Prostate cancer	C61	ESR1; FLT3; EGFR;
C00-D49: Neoplasms	Melanoma	C43	KDR; EGFR;
C00-D49: Neoplasms	Liver cancer	C22	IGF1R; KDR;
C00-D49: Neoplasms	Leukemia	C90-C95	ESR1; FLT3;
NA: NA	Christmas disease	NA	F10;
K00-K95: Diseases of the digestive system	Chemotherapy-induced mucositis	K12.3	MET;
Z00-Z99: Factors influencing health status and contact with health services	Oral contraceptive	Z30	ESR1;
Q00-Q99: Congenital malformations, deformations and chromosomal abnormalities	Osteopetrosis	Q78.2	ESR1;
N00-N99: Diseases of the genitourinary system	Atrophic vaginitis	N95.2	ESR1;
M00-M99: Diseases of the musculoskeletal system and connective tissue	Atrophy	M62.571	ESR1;
L00-L99: Diseases of the skin and subcutaneous tissue	Atopic dermatitis	L00-L99	F2;
E00-E89: Endocrine, nutritional and metabolic diseases	Atrial fibrillation	E78, I48	F10; F2;
E00-E89: Endocrine, nutritional and metabolic diseases	Autoimmune diabetes	E08-E13	ESR1; INSR;
I00-I99: Diseases of the circulatory system	Pulmonary arterial hypertension	I27.0, I27.2	HIF1A;
I00-I99: Diseases of the circulatory system	Venous thrombosis	I80-I82	F10; F2;
I00-I99: Diseases of the circulatory system	Venous thromboembolism	I80-I82	F10; F2;
N00-N99: Diseases of the genitourinary system	Vagina disease	N76.0	ESR1;
C00-D49: Neoplasms	Lung cancer	C33-C34	EGFR;
C00-D49: Neoplasms	Locally advanced head and neck cancer	C07-C14, C32, C33	EGFR;
K00-K95: Diseases of the digestive system	Liver disease	K70-K77	MET;
I00-I99: Diseases of the circulatory system	Cerebrovascular ischaemia	I61-I63	F10; EGFR;
C00-D49: Neoplasms	Ocular cancer	C69	APEX1;
H00-H59: Diseases of the eye and adnexa	Open-angle glaucoma	H40-H42	CA4; ACHE;
H00-H59: Diseases of the eye and adnexa	Ocular hypertension	H40.0	CA4;
NA: NA	Hematopoietic stem cell transplantation	NA	FLT3;
C00-D49: Neoplasms	Adrenocortical carcinoma	C74.0	ESR1;
S00-T88: Injury, poisoning and certain other consequences of external causes	Poison intoxication	T36-T50	ACHE;
E00-E89: Endocrine, nutritional and metabolic diseases	Diabetic neuropathy	E11.40	AKR1B1;
H00-H59: Diseases of the eye and adnexa	Chronic glaucoma	H40-H42	ACHE;
I00-I99: Diseases of the circulatory system	Cardiovascular disorder	I00-I99	KDR; F2;
C00-D49: Neoplasms	Squamous cell cancer of head and neck	NA	KDR;
C00-D49: Neoplasms	Solid tumours	C00-D48	TOP2A; MET; AURKB; IGF1R; KDR; FLT3; HIF1A; TEK; EGFR; SRC; F2;
NA: NA	Menopausal disorder	NA	ESR1;
C00-D49: Neoplasms	Carcinoma	D00-D09	ESR1;
C00-D49: Neoplasms	Cancer	C00-C96	ESR1; PIM1; MET; CDK1; IGF1R; KDR; CSNK2A1; FLT3; ACHE; HIF1A; TEK; EGFR; SRC; F2; CDC25B;
N00-N99: Diseases of the genitourinary system	Menopause symptoms	N95.0	ESR1;
J00-J99: Diseases of the respiratory system	Chronic obstructive pulmonary disease	J40-J44, J47	MMP12;
F01-F99: Mental, Behavioral and Neurodevelopmental disorders	Attention deficit hyperactivity disorder	F90	F10;
E00-E89: Endocrine, nutritional and metabolic diseases	Hypogonadism	E23.0, E28.3, E29.1	ESR1;
M00-M99: Diseases of the musculoskeletal system and connective tissue	Rheumatoid arthritis	M05-M06	AKR1B1;
C00-D49: Neoplasms	Metastasis	C00-C97	AXL;
C00-D49: Neoplasms	Breast cancer	C50	ESR1; CDK1; IGF1R; KDR; FLT3; INSR; EGFR;
D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	Blood forming organ disorders	D75.9	F2;
C00-D49: Neoplasms	Brain cancer	C71, D33	ESR1; EGFR; SRC;
G00-G99: Diseases of the nervous system G00-G99	Parkinson's disease	G20	ACHE;
N00-N99: Diseases of the genitourinary system	Menorrhagia	N92.0	ESR1;
C00-D49: Neoplasms	Metastatic breast cancer	C50	KDR;
C00-D49: Neoplasms	Metastatic HER2-negative gastric cancer	NA	MET;
C00-D49: Neoplasms	Metastatic colorectal cancer	C18-C21	KDR; EGFR;
F01-F99: Mental, Behavioral and Neurodevelopmental disorders	Mild cognitive impairment	F06.7	ACHE;
D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	Blood coagulation disorders	D65-D68	F10; F2;
I00-I99: Diseases of the circulatory system	Bleeding	I74, I80-I82	F10; F2;
C00-D49: Neoplasms	Bladder cancer	C67	EGFR;
C00-D49: Neoplasms	Biliary cancer	C22, C24	KDR;
NA: NA	Gonorrheal vaginitis	NA	ESR1;
M00-M99: Diseases of the musculoskeletal system and connective tissue	Gout	M10	AKR1B1;
C00-D49: Neoplasms	Gliosarcoma	NA	FLT3;
C00-D49: Neoplasms	Glioblastoma	NA	FLT3;
C00-D49: Neoplasms	Glioblastoma multiforme	C71	EGFR; SRC;
NA: NA	GIST	NA	FLT3;
H00-H59: Diseases of the eye and adnexa	Glaucoma	H40-H42	ACHE; AKR1B1;
C00-D49: Neoplasms	Metastatic castration-resistant prostate cancer	C61	KDR;
L00-L99: Diseases of the skin and subcutaneous tissue	Psoriatic disorder	L40	IGF1R;
C00-D49: Neoplasms	Myelodysplastic syndrome	D46	KDR; TEK;
G00-G99: Diseases of the nervous system G00-G99	Myasthenia gravis diagnosis	G70.0	ACHE;
C00-D49: Neoplasms	Gastrointestinal cancers	C15-C26	KDR;
NA: NA	Anaplastic mixed oligoastrocytoma	NA	FLT3;
I00-I99: Diseases of the circulatory system	Stroke in atrial fibrillation	I48, I61-I63	F2;
I00-I99: Diseases of the circulatory system	Heart arrhythmia	I47-I49	F2;
C00-D49: Neoplasms	Head and neck cancer	C07-C14, C32-C33	KDR; EGFR; AKR1B1;
C00-D49: Neoplasms	Head and neck squamous cell carcinoma	C44	EGFR;
I00-I99: Diseases of the circulatory system	Heart disease	I00-I52	MET;
C00-D49: Neoplasms	Lymphoma	C81-C86	HIF1A; INSR; EGFR;
I00-I99: Diseases of the circulatory system	Aortic aneurysm	I71	MMP12;
I00-I99: Diseases of the circulatory system	Angiogenesis disorder	I00-I99	KDR;
F01-F99: Mental, Behavioral and Neurodevelopmental disorders	Anxiety disorder	F32, F40-F42	ACHE;
I00-I99: Diseases of the circulatory system	Acute coronary syndrome	I74	F10;
L00-L99: Diseases of the skin and subcutaneous tissue	Acne vulgaris	L70.0	ESR1;
C00-D49: Neoplasms	Advanced prostate cancer	C61	ESR1;
C00-D49: Neoplasms	Advanced malignancies	C00-C96	KDR;
G00-G99: Diseases of the nervous system G00-G99	Epileptic seizures	G40, P90, R56	ACHE;
I00-I99: Diseases of the circulatory system	Thrombosis	I80-I82	F10; F2;
I00-I99: Diseases of the circulatory system	Thromboembolism	I80-I82	F10; F2;
I00-I99: Diseases of the circulatory system	Thromboembolic disorders	I80-I82	F10;
D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	Thrombocytopenia	D69.6, P61.0	F2;
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified	Growth failure	R62.8	IGF1R;
H00-H59: Diseases of the eye and adnexa	Graves' ophthalmopathy	H06.2	IGF1R;
E00-E89: Endocrine, nutritional and metabolic diseases	Female hypogonadism	E23, E28	ESR1;
J00-J99: Diseases of the respiratory system	Airway inflammation	J00-J99	FLT3;
C00-D49: Neoplasms	Advanced solid tumor	C00-C75, C7A, C7B	MET;
Z00-Z99: Factors influencing health status and contact with health services	Contraception	Z30	ESR1;
C00-D49: Neoplasms	Refractory breast cancer	C50	EGFR;
E00-E89: Endocrine, nutritional and metabolic diseases	Hormone deficiency	E00-E90	ESR1; IGF1R;
C00-D49: Neoplasms	Hormone refractory prostate cancer	C61	ESR1;
NA: NA	Postmenopausal disorder	NA	ESR1;
N00-N99: Diseases of the genitourinary system	Post-menopausal vaginal atrophy	N95.2	ESR1;
G00-G99: Diseases of the nervous system G00-G99	Alzheimer disease	G30	ACHE; INSR;
C00-D49: Neoplasms	AML	NA	KDR; FLT3;
C00-D49: Neoplasms	Fallopian tube cancer	C57.0, D28.2	KDR;
C00-D49: Neoplasms	Thyroid cancer	C73	KDR;
C00-D49: Neoplasms	Hepatocellular carcinoma	C22.0	MET; IGF1R; KDR;
A00-B99: Certain infectious and parasitic diseases	Helminth infection	A00-B99	ACHE;
D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	Hematology	D50-D77	F10;
C00-D49: Neoplasms	Peritoneal cavity cancer	NA	KDR;
S00-T88: Injury, poisoning and certain other consequences of external causes	Poisoning due to pesticides and chemicals	T36-T50	ACHE;
NA: NA	Haemophilia B	NA	F10;
E00-E89: Endocrine, nutritional and metabolic diseases	Hypoglycemia	E16.0-E16.2	INSR;
C00-D49: Neoplasms	Advanced breast cancer	C50	SRC;
C00-D49: Neoplasms	Gastric cancer	C16	KDR; EGFR;
F01-F99: Mental, Behavioral and Neurodevelopmental disorders	Female sexual dysfunction	F52	ESR1;
N00-N99: Diseases of the genitourinary system	Female infertility due to anovulation	N97.0	ESR1;
N00-N99: Diseases of the genitourinary system	Female infertility	N97.0	ESR1;
L00-L99: Diseases of the skin and subcutaneous tissue	Fibrosis	L90.5	MET;
I00-I99: Diseases of the circulatory system	Coagulation	I80-I82	F10; F2;
E00-E89: Endocrine, nutritional and metabolic diseases	Hyperlipidaemia	E78	ESR1; INSR;
C00-D49: Neoplasms	Advanced renal cell carcinoma	C64	KDR;
C00-D49: Neoplasms	Advanced cancers	C00-C96	EGFR;
C00-D49: Neoplasms	Esophageal cancer	C15	EGFR;

Data Section	Select to Download
1. General Info & Plant Usage & Geographical Distribution
2. Human Target Proteins
3. Target Gene Ontology
4. Target KEGG Pathway
5. Related Human Diseases